¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ Á¦2ȸ ¾ÆÅäÇÇÇǺο° Ä¡·á ½ÉÆ÷Áö¿ò : 2023-04-07

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ Á¦2ȸ ¾ÆÅäÇÇÇǺο° Ä¡·á ½ÉÆ÷Áö¿ò : 2023-04-07
±³À°ÀÏÀÚ : 2023-04-07
±³À°Àå¼Ò : ÄÜ·¡µå¼­¿ï ÆÄÅ©º¼·ë(5F)

±³À°ÁÖÁ¦ : Á¦2ȸ ¾ÆÅäÇÇÇǺο° Ä¡·á ½ÉÆ÷Áö¿ò

ÁÖÃÖ±â°ü : ´ëÇÑÇǺΰúÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ

´ã´çÀÚ : ÃÖ°æ¼ö
¿¬¶ôó : 02-2038-7674

À̸ÞÀÏ : gschoi@humming.co.kr

±³À°Á¾·ù : ÇǺΰú

Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 3Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 30ºÐ

¼¼ºÎ¼ö°­·á : 300,000¿ø  

ºñ°í Á¤È¸¿ø,ÁØȸ¿ø-¹«·á/ºñȸ¿ø-30¸¸¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±âŸ 04-08 ÆÄÅ©º¼·ë(5F) 16:00~16:40 µî·Ï ()

±âŸ 04-08 ÆÄÅ©º¼·ë(5F) 16:40~16:50 °³È¸»ç ()

±³À°½Ã°£ 04-08 ÆÄÅ©º¼·ë(5F) 16:50~17:10 Current therapeutic approach for AD °íÇöâ(ºÎ»êÀÇ´ë)

±³À°½Ã°£ 04-08 ÆÄÅ©º¼·ë(5F) 17:10~17:30 Biologics: present and future °íÁÖ¿¬(ÇѾçÀÇ´ë)

±³À°½Ã°£ 04-08 ÆÄÅ©º¼·ë(5F) 17:30~17:50 Janus kinase inhibitors: present and future ÀÌÁöÇö(°¡Å縯ÀÇ´ë)

Åä·Ð 04-08 ÆÄÅ©º¼·ë(5F) 17:50~18:00 Q&A ()

½Ä»ç 04-08 ÆÄÅ©º¼·ë(5F) 18:00~18:50 Àú³á½Ä»ç ()

±³À°½Ã°£ 04-08 ÆÄÅ©º¼·ë(5F) 18:50~19:10 How to select an advanced therapy: biologics or janus kinase inhibitors? Àå¿ëÇö(°æºÏÀÇ´ë)

±³À°½Ã°£ 04-08 ÆÄÅ©º¼·ë(5F) 19:10~19:30 How to monitor while using advanced therapy: efficacies and safety profiles ÇÑÅ¿µ(À»ÁöÀÇ´ë)

±³À°½Ã°£ 04-08 ÆÄÅ©º¼·ë(5F) 19:30~19:50 How to manage an inadequate response: stop, switching, or combination? ÀÌ»óÀº(¿¬¼¼ÀÇ´ë)

Åä·Ð 04-08 ÆÄÅ©º¼·ë(5F) 19:50~20:00 Q&A ()

ÈÞ½Ä 04-08 ÆÄÅ©º¼·ë(5F) 20:00~20:15 Coffee break/booth tour ()

±³À°½Ã°£ 04-08 ÆÄÅ©º¼·ë(5F) 20:15~20:35 Strategies for lesions hard to treat: head and neck, hands and feet ¿ìÀ¯¸®(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 04-08 ÆÄÅ©º¼·ë(5F) 20:35~20:55 Recent advanced therapies in pediatric AD ÀüÁöÇö(°í·ÁÀÇ´ë)

±³À°½Ã°£ 04-08 ÆÄÅ©º¼·ë(5F) 20:55~21:15 Recent advanced therapies in elderly AD ½Å¹Î°æ(°æÈñÀÇ´ë)

Åä·Ð 04-08 ÆÄÅ©º¼·ë(5F) 21:15~21:25 Q&A ()

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ Á¦2ȸ ¾ÆÅäÇÇÇǺο° Ä¡·á ½ÉÆ÷Áö¿ò : 2023-04-07""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Ç÷¿ìº´¿¬±¸È¸ 2023³â µ¿¾Æ½Ã¾Æ Ç÷¿ìº´ Æ÷·³(4¿ù 6ÀÏ) - 2ÀÏÂ÷ : 2023-04-07
´ÙÀ½±Û ´ëÇѼºÇü¿Ü°úÇÐȸ Àü³²´ëÇб³ Çе¿Ä·ÆÛ½º ÀÇ»ý¸í¿¬±¸¿ø 1Ãþ ´ëȸÀÇ½Ç : 2023-04-07
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
435 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ The 17th Postgraduate Course of Diabetes : 2018-09-15 0 845 2018-08-15
434 ÃæºÏ Á¦11Â÷ ´ëÇÑÁßÀçÇ÷°ü¿Ü°úÇÐȸ ½ÉÆ÷Áö¾ö : 2018-09-15 0 879 2018-08-15
433 Á¦ÁÖ ´ëÇÑÄ¡·áÃÊÀ½ÆÄÇÐȸ Á¦4ȸ Á¤±âÇмú´ëȸ : 2018-09-14 0 963 2018-08-15
432 ¼­¿ï Á¦74Â÷ ´ëÇÑ¿µ»óÀÇÇÐȸ Çмú´ëȸ(KCR 2018) 3ÀÏÂ÷ : 2018-09-14 0 2,514 2018-08-15
431 °æ³² ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ ¿µ³²ÁöºÎ 2018³â 9¿ù Áý´ãȸ : 2018-09-14 0 970 2018-08-15
430 °æ±â ±¹¸³¾Ï¼¾ÅÍ 2018³â 3Â÷ ÀÇ»ý¸í°úÇÐÆ÷·³ : 2018-09-14 0 771 2018-08-15
429 ¼­¿ï °¡Å縯´ëÇб³¼­¿ï¼º¸ðº´¿ø °³¿øÀÇ ¿¬¼ö±³À° : 2018-09-14 0 632 2018-08-15
428 ÃæºÏ Á¦11Â÷ ´ëÇÑÁßÀçÇ÷°ü¿Ü°úÇÐȸ ½ÉÆ÷Áö¾ö : 2018-09-14 0 1,483 2018-08-15
427 ¼­¿ï Á¦74Â÷ ´ëÇÑ¿µ»óÀÇÇÐȸ Çмú´ëȸ(KCR 2018) 2ÀÏÂ÷ : 2018-09-13 0 1,551 2018-08-15
426 ¼­¿ï ÀÎÁ¦´ëÇб³»ó°è¹éº´¿ø À̺ñÀÎÈÄ°ú Áý´ãȸ : 2018-09-11 0 509 2018-08-15
425 °æ±â ÇѾç´ëÇб³±¸¸®º´¿ø °©»ó¼± Á¾¾çÀÇ Áø´Ü°ú Ä¡·á: Ãֽŵ¿Çâ : 2018-09-11 0 453 2018-08-15
424 ºÎ»ê Á¦493Â÷ ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ ºÎ»êÁöȸ Áý´ãȸ : 2018-09-10 0 514 2018-08-15
423 ¼­¿ï °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ Á¦ 12ȸ °¡Å縯¼ºÇü½ÉÆ÷Áö¾ö : 2018-09-09 0 801 2018-08-15
422 ¼­¿ï Á߾Ӵ뺴¿ø È£Èí±â¾Ë·¹¸£±â³»°ú ¿¬¼ö°­Á : 2018-09-09 1 797 2018-08-15
421 ¼­¿ï ´ëÇѼºÇü¿Ü°úÇÐȸ Ç׳ëÈ­¼ºÇü¿¬±¸È¸ Á¦4ȸ ½ÉÆ÷Áö¾ö : 2018-09-09 0 811 2018-08-15
1381 | 1382 | 1383 | 1384 | 1385 | 1386 | 1387 | 1388 | 1389 | 1390
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷